Based on analysis of JMJD3 expression in diverse tumor tissues from the oncomine database, Agger et al. found that the expression of JMJD3 was significantly decreased in various cancers, including lung and liver carcinomas, as well as various hematopoietic malignancies6. Here, KDM6B is linked to cancer.